Aerovate Therapeutics, Inc.·4

Feb 8, 6:10 PM ET

Verwijs Marinus 4

4 · Aerovate Therapeutics, Inc. · Filed Feb 8, 2023

Insider Transaction Report

Form 4
Period: 2023-02-07
Verwijs Marinus
Senior Vice President, CMC
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-07+62,00062,000 total
    Exercise: $25.57Exp: 2033-02-06Common Stock (62,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023.

Documents

1 file
  • 4
    form4-02082023_060211.xmlPrimary